Cargando…
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
BACKGROUND: Age-related changes in the cerebrovasculature, including blood–brain barrier (BBB) disruption and vascular dementia, are emerging as potential risks for many neurodegenerative diseases. Therefore, the endothelial cells that constitute the cerebrovasculature may play key roles in preventi...
Autores principales: | Kim, Hyejeong, Noh, Minyoung, Zhang, Haiying, Kim, Yeomyeong, Park, Songyi, Park, Jeongeun, Kwon, Young-Guen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893613/ https://www.ncbi.nlm.nih.gov/pubmed/36726154 http://dx.doi.org/10.1186/s12987-023-00410-x |
Ejemplares similares
-
CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
por: Kim, Ye-Seul, et al.
Publicado: (2020) -
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
por: Kim, Yeomyeong, et al.
Publicado: (2023) -
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells
por: Park, Songyi, et al.
Publicado: (2021) -
CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia–reperfusion injury
por: Zhang, Haiying, et al.
Publicado: (2022) -
CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome
por: Park, Songyi, et al.
Publicado: (2023)